Azebiotics ApS: Financial statements 2024
CVR: 40503021
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Azebiotics ApS (CVR 40503021) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 187,175 and a net result of DKK 176,367 compared with DKK -94,235 the year before. Equity in the 2024 report amounted to DKK -345,815.
- Gross Profit
- DKK 187,175
- Profit/Loss
- DKK 176,367
- Equity
- DKK -345,815
- Total Assets
- DKK 46,489
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 187 t. | 176 t. | -346 t. | - |
| 2023 | - | -104 t. | -94 t. | -522 t. | - |
| 2022 | - | -103 t. | -92 t. | -428 t. | - |
| 2021 | - | -143 t. | -123 t. | -336 t. | - |
| 2020 | - | -186 t. | -225 t. | -213 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Azebiotics ApS has published its annual report for 2023. Gross profit came to DKK -103,696, and the net result was DKK -94,235.
About Azebiotics ApS
Azebiotics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Bender. The company's owners include ECHOSTAR HOLDING ApS, MEVA HOLDING ApS and Frederik Ammitzbøll Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 67,779 and a net result of DKK 57,784 compared with DKK 176,367 the year before. Equity in the 2025 report amounted to DKK -288,030.